NYSE · Healthcare
Encompass Health Corp (EHC)
As-reported financials and recent SEC filings for Encompass Health Corp, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$5.94B
Net income
$566.2M
Net margin
9.5%
Diluted EPS
$5.54
ROE
17.6%
P/E (TTM)
17.4×
Market cap
$10.05B
Debt / equity
0.8×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $5.94B | $5.37B | $4.80B | $4.35B | $4.01B |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | $539.5M | $559.6M |
| Net income | $566.2M | $455.7M | $352.0M | $271.0M | $412.2M |
| Diluted EPS | $5.54 | $4.46 | $3.47 | $2.70 | $4.11 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-01
View on EDGAR →42026-05-18
View on EDGAR →1442026-05-15
View on EDGAR →8-K2026-05-15
View on EDGAR →42026-05-12
View on EDGAR →1442026-05-11
View on EDGAR →8-K2026-05-11
View on EDGAR →42026-05-11
View on EDGAR →Go deeper on EHC
Search Encompass Health Corp’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.